AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2022
Apr 29, 2022
33882_dirs_2022-04-29_e0ec178a-9b67-404e-b028-b2f970ca202f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2022-04-28
Reporting Person: JACOBS CINDY (Director, President & CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-28 | Common Stock | M | 2500 | $0.00 | Acquired | 2723 | Direct |
| 2022-04-28 | Common Stock | F | 609 | $7.43 | Disposed | 2114 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-04-28 | Performance Restricted Stock Unit (PRSU) | $ | M | 2500 | Disposed | 2025-01-26 | Common Stock (2500) | Direct |
Footnotes
F1: Represents shares of common stock acquired upon settlement of the performance restricted stock units ("PRSUs") listed in Table II.
F2: Represents shares of common stock that have been withheld by the issuer to satisfy the tax liability in connection with the settlement of PRSUs.
F3: Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement.
F4: Pursuant to the terms of the PRSU 50% of the total shares underlying the PRSU vest on the achievement of a performance-based milestone, and 50% vest on the first anniversary of the achievement of such milestone.